Urinary Neurotransmitter Testing: Considerations of Spot Baseline Norepinephrine and Epinephrine [Retraction]
Hinz M, Stein A, Uncini T. Res Rep Urol. 2011;3:19–24. The Editor-in-chief and Publisher of Research and Reports in Urology wish to retract the published article. Following the conclusion of our investigation the decision has been made to retract the published article. Th...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-12-01
|
Series: | Research and Reports in Urology |
Subjects: | |
Online Access: | https://www.dovepress.com/retraction-urinary-neurotransmitter-testing-considerations-of-spot-bas-peer-reviewed-article-RRU |
_version_ | 1828946840345640960 |
---|---|
author | Hinz M Stein A Uncini T |
author_facet | Hinz M Stein A Uncini T |
author_sort | Hinz M |
collection | DOAJ |
description | Hinz M, Stein A, Uncini T. Res Rep Urol. 2011;3:19–24.
The Editor-in-chief and Publisher of Research and Reports in Urology wish to retract the published article.
Following the conclusion of our investigation the decision has been made to retract the published article. The authors did not provide the required IRB and informed consent information relating to this study and it was determined the study did not meet the standard ethical publication requirements for studies involving human subjects in research. These requirements are based on guidelines issued by the World Medical Association and the International Committee of Medical Journal Editors. Additionally, the authors did not provide the required study protocols, raw data and other study documents relating to this study as requested. Given our concerns about the standard of research ethics, competing interests and that the authors have not supplied the information we requested to verify and validate the reported findings, the editor has determined the article should be retracted.
Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
This retraction relates to this paper |
first_indexed | 2024-12-14T05:17:16Z |
format | Article |
id | doaj.art-ddb99001e2bc4293a11a9e696894edb5 |
institution | Directory Open Access Journal |
issn | 2253-2447 |
language | English |
last_indexed | 2024-12-14T05:17:16Z |
publishDate | 2020-12-01 |
publisher | Dove Medical Press |
record_format | Article |
series | Research and Reports in Urology |
spelling | doaj.art-ddb99001e2bc4293a11a9e696894edb52022-12-21T23:15:47ZengDove Medical PressResearch and Reports in Urology2253-24472020-12-01Volume 1265966060426Urinary Neurotransmitter Testing: Considerations of Spot Baseline Norepinephrine and Epinephrine [Retraction]Hinz MStein AUncini THinz M, Stein A, Uncini T. Res Rep Urol. 2011;3:19–24. The Editor-in-chief and Publisher of Research and Reports in Urology wish to retract the published article. Following the conclusion of our investigation the decision has been made to retract the published article. The authors did not provide the required IRB and informed consent information relating to this study and it was determined the study did not meet the standard ethical publication requirements for studies involving human subjects in research. These requirements are based on guidelines issued by the World Medical Association and the International Committee of Medical Journal Editors. Additionally, the authors did not provide the required study protocols, raw data and other study documents relating to this study as requested. Given our concerns about the standard of research ethics, competing interests and that the authors have not supplied the information we requested to verify and validate the reported findings, the editor has determined the article should be retracted. Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”. This retraction relates to this paperhttps://www.dovepress.com/retraction-urinary-neurotransmitter-testing-considerations-of-spot-bas-peer-reviewed-article-RRUneurotransmitter testingurinary neurotransmitter testingepinephrine norepinephrineserotonindopamine |
spellingShingle | Hinz M Stein A Uncini T Urinary Neurotransmitter Testing: Considerations of Spot Baseline Norepinephrine and Epinephrine [Retraction] Research and Reports in Urology neurotransmitter testing urinary neurotransmitter testing epinephrine norepinephrine serotonin dopamine |
title | Urinary Neurotransmitter Testing: Considerations of Spot Baseline Norepinephrine and Epinephrine [Retraction] |
title_full | Urinary Neurotransmitter Testing: Considerations of Spot Baseline Norepinephrine and Epinephrine [Retraction] |
title_fullStr | Urinary Neurotransmitter Testing: Considerations of Spot Baseline Norepinephrine and Epinephrine [Retraction] |
title_full_unstemmed | Urinary Neurotransmitter Testing: Considerations of Spot Baseline Norepinephrine and Epinephrine [Retraction] |
title_short | Urinary Neurotransmitter Testing: Considerations of Spot Baseline Norepinephrine and Epinephrine [Retraction] |
title_sort | urinary neurotransmitter testing considerations of spot baseline norepinephrine and epinephrine retraction |
topic | neurotransmitter testing urinary neurotransmitter testing epinephrine norepinephrine serotonin dopamine |
url | https://www.dovepress.com/retraction-urinary-neurotransmitter-testing-considerations-of-spot-bas-peer-reviewed-article-RRU |
work_keys_str_mv | AT hinzm urinaryneurotransmittertestingconsiderationsofspotbaselinenorepinephrineandepinephrineretraction AT steina urinaryneurotransmittertestingconsiderationsofspotbaselinenorepinephrineandepinephrineretraction AT uncinit urinaryneurotransmittertestingconsiderationsofspotbaselinenorepinephrineandepinephrineretraction |